Thomas R. Dean - Weatherford TX Jesse A. May - Fort Worth TX Verney L. Sallee - Burleson TX Louis Desantis, Jr. - Fort Worth TX
Assignee:
Alcon Manufacturing, Ltd. - Fort Worth TX
International Classification:
A61K 31557
US Classification:
514530, 514573, 514912
Abstract:
Disclosed is the use of cloprostenol and fluprostenol analogues in combination with carbonic anhydrase inhibitors for the treatment of glaucoma and ocular hypertension and ophthalmic compositions therefor.
11-Halo Prostaglandins For The Treatment Of Glaucoma Or Ocular Hypertension
Verney L. Sallee - Burleson TX Mark R. Hellberg - Arlington TX Peter G. Klimko - Fort Worth TX Paul W. Zinke - Fort Worth TX
Assignee:
Alcon Laboratories, Inc. - Fort Worth TX
International Classification:
A01N 4316
US Classification:
514310, 549399, 549401, 549429, 560129, 562503
Abstract:
A method of treating glaucoma or ocular hypertension in a patient, which comprises administering to the patient a pharmaceutically effective amount of a compound of formula I:.
15-Ketal Postaglandins For The Treatment Of Glaucoma Or Ocular Hypertension
A method of treating glaucoma or ocular hypertension in a patient, which comprises administering to the patient a pharmaceutically effective amount of a compound of formula I:.
Use Of Cloprostenol And Fluprostenol Analogues To Treat Glaucoma And Ocular Hypertension
Peter G. Klimko - Fort Worth TX John E. Bishop - Groton MA Verney L. Sallee - Burleson TX Paul W. Zinke - Fort Worth TX
Assignee:
Alcon Manufacturing, Ltd. - Fort-Worth TX
International Classification:
A61K 31215
US Classification:
514530, 514573, 514913
Abstract:
Disclosed is the use of cloprostenol and fluprostenol analogues in combination with carbonic anhydrase inhibitors for the treatment of glaucoma and ocular hypertension and ophthalmic compositions therefor.
Peter Klimko - Fort Worth TX, US John Bishop - Groton MA, US Verney Sallee - Burleson TX, US Paul Zinke - Fort Worth TX, US George Barnes - Arlington TX, US Michael Chandler - Crowley TX, US Thomas Dean - Weatherford TX, US Jesse May - Fort Worth TX, US Louis Desantis - Fort Worth TX, US
International Classification:
A61K031/075 A61K031/225
US Classification:
514/548000, 514/719000
Abstract:
Disclosed is the use of cloprostenol and fluprostenol analogues in combination with carbonic anhydrase inhibitors for the treatment of glaucoma and ocular hypertension and ophthalmic compositions therefor.
Cloprostenol And Fluprostenol Analogues And Their Use To Treat Glaucoma And Ocular Hypertension
Peter G. Klimko - Fort Worth TX John E. Bishop - Nashua NH Verney L. Sallee - Burleson TX Paul W. Zinke - Forth Worth TX
Assignee:
Alcon Laboratories, Inc. - Fort Worth TX
International Classification:
A61K 31557 C07C 5946 C07C 69608
US Classification:
514530
Abstract:
Disclosed is the use of cloprostenol and fluprostenol analogues for the treatment of glaucoma and ocular hypertension. Also disclosed are ophthalmic compositions comprising said compounds.
Use Of Trimoprostil And Derivatives In Glaucoma Therapy
Louis M. DeSantis - Fort Worth TX Verney L. Sallee - Southlake TX
Assignee:
Alcon Laboratories, Inc. - Forth Worth TX
International Classification:
A61K 31215 A61K 3119 A61K 31557
US Classification:
514530
Abstract:
Disclosed is the use of trimoprostil, and its derivatives, such as, 15-acetyl trimoprostil and pharmaceutically acceptable salts and esters thereof in the treatment of glaucoma and ocular hypertension. Also disclosed are ophthalmic, pharmaceutical compositions comprising trimoprostil and its derivatives.